Irene Perlich is Principal Accounting Officer of NGM BIOPHARMACEUTICALS INC. Currently has a direct ownership of 0 shares of NGM, which is worth approximately $0. The most recent transaction as insider was on Apr 05, 2024, when has been sold 6,284 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
n/a 12M change
Total Value Held $0

Irene Perlich Transaction History

Date Transaction Value Shares Traded Shares Held Form
Apr 05 2024
SELL
Disposition due to a tender of shares in a change of control transaction
-
6,284 Reduced 100.0%
0 Common Stock
Jan 16 2024
SELL
Payment of exercise price or tax liability
$1,373 $1.34 p/Share
1,025 Reduced 10.25%
8,975 Common Stock
IP

Irene Perlich

Principal Accounting Officer
South San Francisco, CA

Track Institutional and Insider Activities on NGM

Follow NGM BIOPHARMACEUTICALS INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells NGM shares.

Notify only if

Insider Trading

Get notified when an Ngm Biopharmaceuticals Inc insider buys or sells NGM shares.

Notify only if

News

Receive news related to NGM BIOPHARMACEUTICALS INC

Track Activities on NGM